<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32443559</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>May</Month><Day>18</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Human Spinal Motor Neurons Are Particularly Vulnerable to Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3564</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21103564</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is the most common and devastating motor neuron (MN) disease. Its pathophysiological cascade is still enigmatic. More than 90% of ALS patients suffer from sporadic ALS, which makes it specifically demanding to generate appropriate model systems. One interesting aspect considering the seeding, spreading and further disease development of ALS is the cerebrospinal fluid (CSF). We therefore asked whether CSF from sporadic ALS patients is capable of causing disease typical changes in human patient-derived spinal MN cultures and thus could represent a novel model system for sporadic ALS. By using induced pluripotent stem cell (iPSC)-derived MNs from healthy controls and monogenetic forms of ALS we could demonstrate a harmful effect of ALS-CSF on healthy donor-derived human MNs. Golgi fragmentation-a typical finding in lower organism models and human postmortem tissue-was induced solely by addition of ALS-CSF, but not control-CSF. No other neurodegenerative hallmarks-including pathological protein aggregation-were found, underpinning Golgi fragmentation as early event in the neurodegenerative cascade. Of note, these changes occurred predominantly in MNs, the cell type primarily affected in ALS. We thus present a novel way to model early features of sporadic ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Br&#xe4;uer</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2449-5530</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, St&#xe4;dtisches Klinikum Dresden, 01129 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;nther</LastName><ForeName>Ren&#xe9;</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterneckert</LastName><ForeName>Jared</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Regenerative Therapies Dresden (CRTD), Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gla&#xdf;</LastName><ForeName>Hannes</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Translational Neurodegeneration Section "Albrecht-Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermann</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7364-7791</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Neurodegeneration Section "Albrecht-Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) Rostock, 18147 Rostock, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>none</GrantID><Agency>Schilling Stiftung im Stifterverband</Agency><Country/></Grant><Grant><GrantID>He2/2</GrantID><Agency>Deutsche Gesellschaft f&#xfc;r Muskelerkrankungen</Agency><Country/></Grant><Grant><GrantID>none</GrantID><Agency>NOMIS Foundation</Agency><Country/></Grant><Grant><GrantID>VH-VI-510</GrantID><Agency>Helmholtz Virtual Institute "RNA dysmetabolism in ALS and FTD</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002555" MajorTopicYN="N">Cerebrospinal Fluid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006056" MajorTopicYN="N">Golgi Apparatus</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="Y">Protein Aggregation, Pathological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Golgi fragmentation</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">cerebrospinal fluid</Keyword><Keyword MajorTopicYN="N">fused in sarcoma</Keyword><Keyword MajorTopicYN="N">superoxide dismutase 1</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32443559</ArticleId><ArticleId IdType="pmc">PMC7278966</ArticleId><ArticleId IdType="doi">10.3390/ijms21103564</ArticleId><ArticleId IdType="pii">ijms21103564</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brauer S., Zimyanin V., Hermann A. Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis. J. Neural Transm. 2018;125:591&#x2013;613. doi: 10.1007/s00702-018-1851-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-018-1851-y</ArticleId><ArticleId IdType="pubmed">29417336</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R., Myers K., Ravits J., Bowser R. Amyotrophic lateral sclerosis: Is the spinal fluid pathway involved in seeding and spread? Med. Hypotheses. 2015;85:576&#x2013;583. doi: 10.1016/j.mehy.2015.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2015.07.014</ArticleId><ArticleId IdType="pubmed">26220261</ArticleId></ArticleIdList></Reference><Reference><Citation>Couratier P., Hugon J., Sindou P., Vallat J.M., Dumas M. Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors. Lancet. 1993;341:265&#x2013;268. doi: 10.1016/0140-6736(93)92615-Z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0140-6736(93)92615-Z</ArticleId><ArticleId IdType="pubmed">8093916</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Pinedo U., Galan L., Yanez M., Matias-Guiu J., Valencia C., Guerrero-Sola A., Lopez-Sosa F., Brin J.R., Benito-Martin M.S., Leon-Espinosa G., et al. Histological changes in the rat brain and spinal cord following prolonged intracerebroventricular infusion of cerebrospinal fluid from amyotrophic lateral sclerosis patients are similar to those caused by the disease. Neurologia. 2018;33:211&#x2013;223. doi: 10.1016/j.nrleng.2016.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrleng.2016.07.002</ArticleId><ArticleId IdType="pubmed">27570180</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Pinedo U., Yanez M., Matias-Guiu J., Galan L., Guerrero-Sola A., Benito-Martin M.S., Vela A., Arranz-Tagarro J.A., Garcia A.G. Cellular changes in motor neuron cell culture produced by cytotoxic cerebrospinal fluid from patients with amyotrophic lateral sclerosis. Neurologia. 2014;29:346&#x2013;352. doi: 10.1016/j.nrl.2013.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2013.08.001</ArticleId><ArticleId IdType="pubmed">24144827</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayalakshmi K., Alladi P.A., Ghosh S., Prasanna V.K., Sagar B.C., Nalini A., Sathyaprabha T.N., Raju T.R. Evidence of endoplasmic reticular stress in the spinal motor neurons exposed to CSF from sporadic amyotrophic lateral sclerosis patients. Neurobiol. Dis. 2011;41:695&#x2013;705. doi: 10.1016/j.nbd.2010.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2010.12.005</ArticleId><ArticleId IdType="pubmed">21168498</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanez M., Galan L., Matias-Guiu J., Vela A., Guerrero A., Garcia A.G. CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons: Protection by resveratrol but not riluzole. Brain Res. 2011;1423:77&#x2013;86. doi: 10.1016/j.brainres.2011.09.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2011.09.025</ArticleId><ArticleId IdType="pubmed">21983205</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X., Ma M., Teng J., Teng R.K., Zhou S., Yin J., Fonkem E., Huang J.H., Wu E., Wang X. Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure. Oncotarget. 2015;6:24178&#x2013;24191. doi: 10.18632/oncotarget.4680.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.4680</ArticleId><ArticleId IdType="pmc">PMC4695178</ArticleId><ArticleId IdType="pubmed">26172304</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao M.S., Devi M.G., Nalini A., Shahani N., Raju T.R. Neurofilament phosphorylation is increased in ventral horn neurons of neonatal rat spinal cord exposed to cerebrospinal fluid from patients with amyotrophic lateral sclerosis. Neurodegeneration. 1995;4:397&#x2013;401. doi: 10.1006/neur.1995.0048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/neur.1995.0048</ArticleId><ArticleId IdType="pubmed">8846233</ArticleId></ArticleIdList></Reference><Reference><Citation>Shobha K., Alladi P.A., Nalini A., Sathyaprabha T.N., Raju T.R. Exposure to CSF from sporadic amyotrophic lateral sclerosis patients induces morphological transformation of astroglia and enhances GFAP and S100beta expression. Neurosci. Lett. 2010;473:56&#x2013;61. doi: 10.1016/j.neulet.2010.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2010.02.022</ArticleId><ArticleId IdType="pubmed">20170712</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Varghese A.M., Vijaylakshmi K., Sumitha R., Prasanna V.K., Shruthi S., Chandrasekhar Sagar B.K., Datta K.K., Gowda H., Nalini A., et al. Cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients induces mitochondrial and lysosomal dysfunction. Neurochem. Res. 2016;41:965&#x2013;984. doi: 10.1007/s11064-015-1779-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-015-1779-7</ArticleId><ArticleId IdType="pubmed">26646005</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramamohan P.Y., Gourie-Devi M., Nalini A., Shobha K., Ramamohan Y., Joshi P., Raju T.R. Cerebrospinal fluid from amyotrophic lateral sclerosis patients causes fragmentation of the Golgi apparatus in the neonatal rat spinal cord. Amyotroph. Lateral Scler. 2007;8:79&#x2013;82. doi: 10.1080/08037060601145489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08037060601145489</ArticleId><ArticleId IdType="pubmed">17453633</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaramoorthy V., Walker A.K., Yerbury J., Soo K.Y., Farg M.A., Hoang V., Zeineddine R., Spencer D., Atkin J.D. Extracellular wildtype and mutant SOD1 induces ER-Golgi pathology characteristic of amyotrophic lateral sclerosis in neuronal cells. Cell. Mol. Life Sci. 2013;70:4181&#x2013;4195. doi: 10.1007/s00018-013-1385-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1385-2</ArticleId><ArticleId IdType="pubmed">23765103</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagomi S., Barsoum M.J., Bossy-Wetzel E., Sutterlin C., Malhotra V., Lipton S.A. A Golgi fragmentation pathway in neurodegeneration. Neurobiol. Dis. 2008;29:221&#x2013;231. doi: 10.1016/j.nbd.2007.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.08.015</ArticleId><ArticleId IdType="pmc">PMC2261378</ArticleId><ArticleId IdType="pubmed">17964175</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaramoorthy V., Sultana J.M., Atkin J.D. Golgi fragmentation in amyotrophic lateral sclerosis, an overview of possible triggers and consequences. Front. Neurosci. 2015;9:400. doi: 10.3389/fnins.2015.00400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2015.00400</ArticleId><ArticleId IdType="pmc">PMC4621950</ArticleId><ArticleId IdType="pubmed">26578862</ArticleId></ArticleIdList></Reference><Reference><Citation>Stieber A., Gonatas J.O., Collard J., Meier J., Julien J., Schweitzer P., Gonatas N.K. The neuronal Golgi apparatus is fragmented in transgenic mice expressing a mutant human SOD1, but not in mice expressing the human NF-H gene. J. Neurol. Sci. 2000;173:63&#x2013;72. doi: 10.1016/S0022-510X(99)00301-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00301-9</ArticleId><ArticleId IdType="pubmed">10675581</ArticleId></ArticleIdList></Reference><Reference><Citation>Stieber A., Gonatas J.O., Moore J.S., Bantly A., Yim H.S., Yim M.B., Gonatas N.K. Disruption of the structure of the Golgi apparatus and the function of the secretory pathway by mutants G93A and G85R of Cu, Zn superoxide dismutase (SOD1) of familial amyotrophic lateral sclerosis. J. Neurol. Sci. 2004;219:45&#x2013;53. doi: 10.1016/j.jns.2003.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2003.12.004</ArticleId><ArticleId IdType="pubmed">15050437</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita Y., Mizuno Y., Takatama M., Okamoto K. Anterior horn cells with abnormal TDP-43 immunoreactivities show fragmentation of the Golgi apparatus in ALS. J. Neurol. Sci. 2008;269:30&#x2013;34. doi: 10.1016/j.jns.2007.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.12.016</ArticleId><ArticleId IdType="pubmed">18206910</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita Y., Okamoto K., Sakurai A., Amari M., Nakazato Y., Gonatas N.K. Fragmentation of the Golgi apparatus of Betz cells in patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 1999;163:81&#x2013;85. doi: 10.1016/S0022-510X(99)00014-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00014-3</ArticleId><ArticleId IdType="pubmed">10223416</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita Y., Okamoto K., Sakurai A., Gonatas N.K., Hirano A. Fragmentation of the Golgi apparatus of the anterior horn cells in patients with familial amyotrophic lateral sclerosis with SOD1 mutations and posterior column involvement. J. Neurol. Sci. 2000;174:137&#x2013;140. doi: 10.1016/S0022-510X(00)00265-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(00)00265-3</ArticleId><ArticleId IdType="pubmed">10727699</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonatas N.K., Stieber A., Mourelatos Z., Chen Y., Gonatas J.O., Appel S.H., Hays A.P., Hickey W.F., Hauw J.J. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. Am. J. Pathol. 1992;140:731&#x2013;737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886164</ArticleId><ArticleId IdType="pubmed">1546747</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourelatos Z., Adler H., Hirano A., Donnenfeld H., Gonatas J.O., Gonatas N.K. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis revealed by organelle-specific antibodies. Proc. Natl. Acad. Sci. USA. 1990;87:4393&#x2013;4395. doi: 10.1073/pnas.87.11.4393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.87.11.4393</ArticleId><ArticleId IdType="pmc">PMC54116</ArticleId><ArticleId IdType="pubmed">2349244</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourelatos Z., Hirano A., Rosenquist A.C., Gonatas N.K. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis (ALS). Clinical studies in ALS of Guam and experimental studies in deafferented neurons and in beta, beta&#x2019;-iminodipropionitrile axonopathy. Am. J. Pathol. 1994;144:1288&#x2013;1300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1887469</ArticleId><ArticleId IdType="pubmed">8203467</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourelatos Z., Yachnis A., Rorke L., Mikol J., Gonatas N.K. The Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. Ann. Neurol. 1993;33:608&#x2013;615. doi: 10.1002/ana.410330609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410330609</ArticleId><ArticleId IdType="pubmed">8498841</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita Y., Ohama E., Takatama M., Al-Sarraj S., Okamoto K. Fragmentation of Golgi apparatus of nigral neurons with alpha-synuclein-positive inclusions in patients with Parkinson&#x2019;s disease. Acta Neuropathol. 2006;112:261&#x2013;265. doi: 10.1007/s00401-006-0114-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-006-0114-4</ArticleId><ArticleId IdType="pubmed">16855830</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonatas N.K., Stieber A., Gonatas J.O. Fragmentation of the Golgi apparatus in neurodegenerative diseases and cell death. J. Neurol. Sci. 2006;246:21&#x2013;30. doi: 10.1016/j.jns.2006.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2006.01.019</ArticleId><ArticleId IdType="pubmed">16545397</ArticleId></ArticleIdList></Reference><Reference><Citation>Maekawa T., Mori S., Sasaki Y., Miyajima T., Azuma S., Ohta E., Obata F. The I2020T Leucine-rich repeat kinase 2 transgenic mouse exhibits impaired locomotive ability accompanied by dopaminergic neuron abnormalities. Mol. Neurodegener. 2012;7:15. doi: 10.1186/1750-1326-7-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-15</ArticleId><ArticleId IdType="pmc">PMC3467184</ArticleId><ArticleId IdType="pubmed">22534020</ArticleId></ArticleIdList></Reference><Reference><Citation>Stieber A., Mourelatos Z., Gonatas N.K. In Alzheimer&#x2019;s disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic. Am. J. Pathol. 1996;148:415&#x2013;426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1861703</ArticleId><ArticleId IdType="pubmed">8579105</ArticleId></ArticleIdList></Reference><Reference><Citation>Stieber A., Chen Y., Wei S., Mourelatos Z., Gonatas J., Okamoto K., Gonatas N.K. The fragmented neuronal Golgi apparatus in amyotrophic lateral sclerosis includes the trans-Golgi-network: Functional implications. Acta Neuropathol. 1998;95:245&#x2013;253. doi: 10.1007/s004010050794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010050794</ArticleId><ArticleId IdType="pubmed">9542589</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dis V., Kuijpers M., Haasdijk E.D., Teuling E., Oakes S.A., Hoogenraad C.C., Jaarsma D. Golgi fragmentation precedes neuromuscular denervation and is associated with endosome abnormalities in SOD1-ALS mouse motor neurons. Acta Neuropathol. Commun. 2014;2:38. doi: 10.1186/2051-5960-2-38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-2-38</ArticleId><ArticleId IdType="pmc">PMC4023628</ArticleId><ArticleId IdType="pubmed">24708899</ArticleId></ArticleIdList></Reference><Reference><Citation>Rendon W.O., Martinez-Alonso E., Tomas M., Martinez-Martinez N., Martinez-Menarguez J.A. Golgi fragmentation is Rab and SNARE dependent in cellular models of Parkinson&#x2019;s disease. Histochem. Cell Biol. 2013;139:671&#x2013;684. doi: 10.1007/s00418-012-1059-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00418-012-1059-4</ArticleId><ArticleId IdType="pubmed">23212845</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita Y., Okamoto K. Golgi apparatus of the motor neurons in patients with amyotrophic lateral sclerosis and in mice models of amyotrophic lateral sclerosis. Neuropathology. 2005;25:388&#x2013;394. doi: 10.1111/j.1440-1789.2005.00616.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2005.00616.x</ArticleId><ArticleId IdType="pubmed">16382790</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourelatos Z., Gonatas N.K., Stieber A., Gurney M.E., Dal Canto M.C. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu, Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc. Natl. Acad. Sci. USA. 1996;93:5472&#x2013;5477. doi: 10.1073/pnas.93.11.5472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.11.5472</ArticleId><ArticleId IdType="pmc">PMC39270</ArticleId><ArticleId IdType="pubmed">8643599</ArticleId></ArticleIdList></Reference><Reference><Citation>Japtok J., Lojewski X., Naumann M., Klingenstein M., Reinhardt P., Sterneckert J., Putz S., Demestre M., Boeckers T.M., Ludolph A.C., et al. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging. Neurobiol. Dis. 2015;82:420&#x2013;429. doi: 10.1016/j.nbd.2015.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.07.017</ArticleId><ArticleId IdType="pubmed">26253605</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Pal A., Goswami A., Lojewski X., Japtok J., Vehlow A., Naujock M., Gunther R., Jin M., Stanslowsky N., et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat. Commun. 2018;9:335. doi: 10.1038/s41467-017-02299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Abo-Rady M., Kalmbach N., Pal A., Schludi C., Janosch A., Richter T., Freitag P., Bickle M., Kahlert A.K., Petri S., et al. Knocking out C9ORF72 Exacerbates Axonal Trafficking Defects Associated with Hexanucleotide Repeat Expansion and Reduces Levels of Heat Shock Proteins. Stem Cell Rep. 2020 doi: 10.1016/j.stemcr.2020.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2020.01.010</ArticleId><ArticleId IdType="pmc">PMC7066330</ArticleId><ArticleId IdType="pubmed">32084385</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreiter N., Pal A., Lojewski X., Corcia P., Naujock M., Reinhardt P., Sterneckert J., Petri S., Wegner F., Storch A., et al. Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation. Neurobiol. Dis. 2018;115:167&#x2013;181. doi: 10.1016/j.nbd.2018.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.03.010</ArticleId><ArticleId IdType="pubmed">29630989</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal A., Glass H., Naumann M., Kreiter N., Japtok J., Sczech R., Hermann A. High content organelle trafficking enables disease state profiling as powerful tool for disease modelling. Sci. Data. 2018;5:180241. doi: 10.1038/sdata.2018.241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2018.241</ArticleId><ArticleId IdType="pmc">PMC6233479</ArticleId><ArticleId IdType="pubmed">30422121</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H., Brettschneider J., Ludolph A.C., Lee V.M., Trojanowski J.Q., Del Tredici K. Amyotrophic lateral sclerosis&#x2014;A model of corticofugal axonal spread. Nat. Rev. Neurol. 2013;9:708&#x2013;714. doi: 10.1038/nrneurol.2013.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.221</ArticleId><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J., Comley L.H., Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885. doi: 10.1007/s00401-017-1708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomura T., Watanabe S., Kaneko K., Yamanaka K., Nukina N., Furukawa Y. Intranuclear aggregation of mutant FUS/TLS as a molecular pathomechanism of amyotrophic lateral sclerosis. J. Biol. Chem. 2014;289:1192&#x2013;1202. doi: 10.1074/jbc.M113.516492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.516492</ArticleId><ArticleId IdType="pmc">PMC3887186</ArticleId><ArticleId IdType="pubmed">24280224</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudlo J., Konig J., Schuster C., Kasper E., Buttner A., Teipel S., Neumann M. TDP-43 pathology and cognition in ALS: A prospective clinicopathologic correlation study. Neurology. 2016;87:1019&#x2013;1023. doi: 10.1212/WNL.0000000000003062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003062</ArticleId><ArticleId IdType="pubmed">27488596</ArticleId></ArticleIdList></Reference><Reference><Citation>Munch C., O&#x2019;Brien J., Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc. Natl. Acad. Sci. USA. 2011;108:3548&#x2013;3553. doi: 10.1073/pnas.1017275108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017275108</ArticleId><ArticleId IdType="pmc">PMC3048161</ArticleId><ArticleId IdType="pubmed">21321227</ArticleId></ArticleIdList></Reference><Reference><Citation>Budini M., Romano V., Avendano-Vazquez S.E., Bembich S., Buratti E., Baralle F.E. Role of selected mutations in the Q/N rich region of TDP-43 in EGFP-12xQ/N-induced aggregate formation. Brain Res. 2012;1462:139&#x2013;150. doi: 10.1016/j.brainres.2012.02.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.02.031</ArticleId><ArticleId IdType="pubmed">22406069</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Chen Y., Zhou X., Kar A., Ray P., Chen X., Rao E.J., Yang M., Ye H., Zhu L., et al. An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat. Struct. Mol. Biol. 2011;18:822&#x2013;830. doi: 10.1038/nsmb.2053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2053</ArticleId><ArticleId IdType="pmc">PMC3357956</ArticleId><ArticleId IdType="pubmed">21666678</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson B.S., Snead D., Lee J.J., McCaffery J.M., Shorter J., Gitler A.D. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 2009;284:20329&#x2013;20339. doi: 10.1074/jbc.M109.010264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.010264</ArticleId><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>Galan L., Matias-Guiu J., Matias-Guiu J.A., Yanez M., Pytel V., Guerrero-Sola A., Vela-Souto A., Arranz-Tagarro J.A., Gomez-Pinedo U., Garcia A.G. Cerebrospinal fluid cytotoxicity does not affect survival in amyotrophic lateral sclerosis. Acta Neurol. Scand. 2017;136:212&#x2013;216. doi: 10.1111/ane.12717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12717</ArticleId><ArticleId IdType="pubmed">28032330</ArticleId></ArticleIdList></Reference><Reference><Citation>Buddensiek J., Dressel A., Kowalski M., Runge U., Schroeder H., Hermann A., Kirsch M., Storch A., Sabolek M. Cerebrospinal fluid promotes survival and astroglial differentiation of adult human neural progenitor cells but inhibits proliferation and neuronal differentiation. BMC Neurosci. 2010;11:48. doi: 10.1186/1471-2202-11-48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-11-48</ArticleId><ArticleId IdType="pmc">PMC2856586</ArticleId><ArticleId IdType="pubmed">20377845</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass H., Neumann P., Pal A., Reinhardt P., Storch A., Sterneckert J., Hermann A. Combined dendritic and axonal deterioration are responsible for motoneuronopathy in patient-derived neuronal cell models of chorea-acanthocytosis. Int. J. Mol. Sci. 2020;21:1797. doi: 10.3390/ijms21051797.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21051797</ArticleId><ArticleId IdType="pmc">PMC7084777</ArticleId><ArticleId IdType="pubmed">32151030</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>